Selene Koo

19PUBLICATIONS
89CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 03, 2026
MYOD1 mutation drives cancer stem cell pathways and therapy-resistance in spindle cell/sclerosing rhabdomyosarcoma.

|Mar 03, 2026
Novel EPS15 :: KLF17 and EPS15L1 :: KLF17 Fusions Define a Distinctive Group of MUC4-Positive Spindled to Epithelioid Sarcomas.

Faizan Malik, Maia Vong, Carina A Dehner

|Feb 02, 2026
LRRC15-CAR T Cells for the Treatment of Osteosarcoma.

Carla O'Reilly, Shraddha Tuladhar, Phuong Nguyen

|Feb 28, 2025
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid.

Min Pan, Yinwen Zhang, William C Wright

|Nov 10, 2024
Genomic profiling of circulating tumor DNA for childhood cancers.

Shaohua Lei, Sujuan Jia, Sunitha Takalkar

|Aug 07, 2024
SMARCA4-deficient primary bone sarcoma with "teratoid" features in a rhabdoid tumor predisposition syndrome patient.

Jonathan Sookdeo, Lu Wang, Michael W Bishop

Pageof 4

Frequent Collaborators

5 joint publications

Heather Sheppard

4 joint publications

Kathleen M Schieffer

3 joint publications

Liqing Tian

3 joint publications

Stephen Gottschalk